Punk rock Leukemia PharmD, researcher, and educator. Mom goals. @MDAndersonNews | @UGAPharmacy + R406 @UK_HealthCare residency trained. Tweets are my own.
Houston, TX
Joined March 2009
- Tweets4.9K
- Following427
- Followers934
- Likes3.8K
Kayleigh Marx, PharmD, BCOP retweeted
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL) | Leukemia nature.com/articles/s41375-0…
Kayleigh Marx, PharmD, BCOP retweeted
The 17 fired members of ACIP, including me, have written an article in JAMA about our experience and our concerns.
jamanetwork.com/journals/jam…
Kayleigh Marx, PharmD, BCOP retweeted
Sorry to learn, thanks for sharing. Let’s see what the subgroup analyses reveal: bridged to alloSCT vs. Not, ASXL1mut vs. Not etc.
Kayleigh Marx, PharmD, BCOP retweeted
The Journal of Hematology Oncology Pharmacy (@JHOPjournal) is recruiting HOPA members to serve as manuscript reviewers. This opportunity is ideal for young professionals who are looking to gain expertise in scholarly manuscripts.
Apply today: bit.ly/3JoBG7W
Kayleigh Marx, PharmD, BCOP retweeted
👉👉 Happy to share results of investigator initiated trial of Ruxolitinib in Ph-Like ALL. We did not see any significant responses in R/R adult Ph-like B-ALL with ruxolitinib.
👉Looking back at my emails @mkonople and I had initial discussions with Incyte for this trial at ASH 2013!
First patient enrolled Oct 2015
👉Thanks much @HannahGoulart for helping summarize the trial
@MDAndersonNews
sciencedirect.com/science/ar…
Kayleigh Marx, PharmD, BCOP retweeted
👉👉👉Our group’s new article led by Dr @HannahGoulart & Dr @TapKadia Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia AML
acsjournals.onlinelibrary.wi… | @JournalCancer @MDAndersonNews #leusm #endcancer | @sanamloghavi
Kayleigh Marx, PharmD, BCOP retweeted
Multicenter retrospective evaluation of treatment for high risk acute promyelocytic #leukemia:
Comparison of the APML4 and ATRA+ATO+GO in high risk #APL conducted by the @HERO_consortium
Free access: doi.org/10.1002/ajh.27667 #LeuSM
@Berninini #HemOnc
Kayleigh Marx, PharmD, BCOP retweeted
BIG WIN! 🏆
A recent bibliometric analysis published in @CPTLJournal recognizes @UK_COP as a global leader in pharmacy education research. The study ranks UKCOP as the #2 most productive institution worldwide, with 61 publications and 1,127 citations—a testament to the College’s groundbreaking contributions to the field.
Adding to this achievement, @DrJeffCain, professor and vice-chair of Pharmacy Practice & Science, has been named one of the top 10 most prolific authors in pharmacy education research, further solidifying the College’s impact on shaping the future of pharmacy education.
READ: bit.ly/3CVMzO8
@ResearchKY #pharmed #TwitteRx
ALT A person presenting a scientific poster to another attendee at a conference, with other participants in the background.
ALT Attendees at a conference view and discuss posters in a hallway.
ALT Person holding documents converses with another person in a conference setting, with other participants in the background.
ALT Two people discussing a presentation board at a UK HealthCare event.
Kayleigh Marx, PharmD, BCOP retweeted
Your Voice Matters. Your Vote Matters. Board Elections are now open through December 2 - find out more about the candidates, and how to cast your ballot, at the HOPA Election Center: bit.ly/3Mmrkqa
Kayleigh Marx, PharmD, BCOP retweeted
👉👉👉Congratulations 🎉 to our own Leukemia PharmD * Dr Adam DiPippo * PharmD for winning 🏅 Clinical Pharmacist of The Year 2024 Award @MDAndersonNews !!! #PharmD #endcancer #leusm @DrHKantarjian @GBorthakur @Marxk @TapKadia @doctorpemm @AlisonGulbis
Kayleigh Marx, PharmD, BCOP retweeted
Excited to see this in print! An #oncopharm collaboration between 4 centers 👏
With so many new #celltherapy & #genetherapy approvals, centers have to remain agile & develop sustainable methods but it must be done thoughtfully and w/the multidisciplinary care team.
@TheIACH
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
just Published in Clinical Hematology International the official journal of @TheIACH @OlaOluwole4 @BipinSavani @UsuarezMD chi.scholasticahq.com/articl…
Kayleigh Marx, PharmD, BCOP retweeted
FHOPA recognitions at #HOPA2024 featured a rockstar lineup of #pharmacytarheels. Congratulations to @Benyam_Muluneh @lindseyamerine and @lwbpharmd on a well deserved recognition!!!!
Kayleigh Marx, PharmD, BCOP retweeted
Wow the FDA has been on a roll
This Post is from an account that no longer exists. Learn more
Kayleigh Marx, PharmD, BCOP retweeted
Today, I am excited to share the first major deliverable from our White House Initiative on Women’s Health Research:
$100 million in funding for women's health research and development as part of ARPA-H's first-ever Sprint for Women’s Health.
Together, we will build a new future for women’s health. We will close research gaps, accelerate new ideas, and change women’s lives.
Kayleigh Marx, PharmD, BCOP retweeted
I know her!!!!! @VictoriaNachar
👏congrats and thanks to @VictoriaNachar for representing #oncopharm on this super important issue. We finally have consensus guidelines on how to manage these common toxicities! doi.org/10.1182/blood.202302…
Kayleigh Marx, PharmD, BCOP retweeted
Important for Medicare recipients:
Starting this year, your annual out of pocket expenses for Part D prescription meds will be capped. This is a huge relief.
For 2024, the maximum you will pay will be ~$3250.
1/ @ASlavitt
Kayleigh Marx, PharmD, BCOP retweeted
Dose-dense mini-hyper-CVD, INO and blina achieves NGS MRD negativity in >90% of pts with new dx B-ALL. A clinical trial at @MDAndersonNews is ongoing.
@NicholasShortMD
Clinical Lymphoma, Myeloma and Leukemia
clinical-lymphoma-myeloma-le…
